Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood pressure cuff aims to replace needles for tiny patients

NCT ID NCT07684885

Recruiting now Knowledge-focused Sponsor: GE Healthcare Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a new non-invasive blood pressure (NIBP) device in newborns and children up to 18 years old. The device uses a cuff on the arm or thigh to measure blood pressure without needles. Researchers compare these readings to standard invasive measurements to see how accurate the new method is. If it works well, it could offer a safer, less painful way to monitor blood pressure in young patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate, cuff-based blood pressure monitor for infants and children, reducing the need for invasive lines.
What could go wrong
This is an early-stage accuracy study, not a treatment trial. The device may not perform as well as expected across all ages and sizes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD PRESSURE BLOOD PRESSURE MEASUREMENT

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Helsinki University Hospital

    RECRUITING

    Helsinki, 00290, Finland

  • Helsinki University Hospital

    RECRUITING

    Helsinki, 00290, Finland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.